| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 4.20e-05 | 21 | 65 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 6.23e-05 | 4 | 65 | 2 | GO:0003873 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 1.04e-04 | 5 | 65 | 2 | GO:0004331 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 2.17e-04 | 7 | 65 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | sugar-phosphatase activity | 4.62e-04 | 10 | 65 | 2 | GO:0050308 | |
| GeneOntologyMolecularFunction | carbohydrate phosphatase activity | 5.63e-04 | 11 | 65 | 2 | GO:0019203 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 9.76e-05 | 5 | 66 | 2 | GO:1990513 | |
| Domain | Envoplakin | 1.27e-05 | 2 | 67 | 2 | IPR030460 | |
| Domain | 6Pfruct_kin | 7.57e-05 | 4 | 67 | 2 | IPR003094 | |
| Domain | 6Phosfructo_kin | 7.57e-05 | 4 | 67 | 2 | IPR013079 | |
| Domain | 6PF2K | 7.57e-05 | 4 | 67 | 2 | PF01591 | |
| Domain | PrprotnconvertsP | 2.63e-04 | 7 | 67 | 2 | IPR002884 | |
| Domain | P_proprotein | 2.63e-04 | 7 | 67 | 2 | PF01483 | |
| Domain | S8_pro-domain | 2.63e-04 | 7 | 67 | 2 | IPR032815 | |
| Domain | - | 2.63e-04 | 7 | 67 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 2.63e-04 | 7 | 67 | 2 | PF16470 | |
| Domain | Nuc_translocat | 3.50e-04 | 8 | 67 | 2 | IPR001067 | |
| Domain | Peptidase_S8_His-AS | 4.49e-04 | 9 | 67 | 2 | IPR022398 | |
| Domain | PG/BPGM_mutase_AS | 4.49e-04 | 9 | 67 | 2 | IPR001345 | |
| Domain | Peptidase_S8_Ser-AS | 4.49e-04 | 9 | 67 | 2 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 5.60e-04 | 10 | 67 | 2 | IPR015500 | |
| Domain | PGAM | 5.60e-04 | 10 | 67 | 2 | SM00855 | |
| Domain | SUBTILASE_ASP | 5.60e-04 | 10 | 67 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 5.60e-04 | 10 | 67 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 5.60e-04 | 10 | 67 | 2 | PS00138 | |
| Domain | PG_MUTASE | 5.60e-04 | 10 | 67 | 2 | PS00175 | |
| Domain | - | 6.83e-04 | 11 | 67 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 6.83e-04 | 11 | 67 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 6.83e-04 | 11 | 67 | 2 | PF00082 | |
| Domain | His_Phos_1 | 8.18e-04 | 12 | 67 | 2 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 8.18e-04 | 12 | 67 | 2 | IPR013078 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.12e-03 | 14 | 67 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.12e-03 | 14 | 67 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.12e-03 | 14 | 67 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.12e-03 | 14 | 67 | 2 | PF08393 | |
| Domain | MT | 1.12e-03 | 14 | 67 | 2 | PF12777 | |
| Domain | AAA_8 | 1.12e-03 | 14 | 67 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.12e-03 | 14 | 67 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.12e-03 | 14 | 67 | 2 | PF07728 | |
| Domain | DHC_fam | 1.29e-03 | 15 | 67 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.29e-03 | 15 | 67 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.29e-03 | 15 | 67 | 2 | PF03028 | |
| Domain | Propept_inh | 1.67e-03 | 17 | 67 | 2 | IPR009020 | |
| Domain | - | 2.29e-03 | 73 | 67 | 3 | 2.60.120.260 | |
| Domain | His_PPase_superfam | 2.31e-03 | 20 | 67 | 2 | IPR029033 | |
| Domain | - | 2.31e-03 | 20 | 67 | 2 | 3.40.50.1240 | |
| Domain | FG_GAP | 2.80e-03 | 22 | 67 | 2 | PS51470 | |
| Domain | PAS_fold_3 | 3.06e-03 | 23 | 67 | 2 | IPR013655 | |
| Domain | PAS_3 | 3.06e-03 | 23 | 67 | 2 | PF08447 | |
| Domain | FG-GAP | 3.33e-03 | 24 | 67 | 2 | PF01839 | |
| Domain | FG-GAP | 3.33e-03 | 24 | 67 | 2 | IPR013517 | |
| Domain | PAS | 3.61e-03 | 25 | 67 | 2 | PF00989 | |
| Domain | PAS_fold | 3.61e-03 | 25 | 67 | 2 | IPR013767 | |
| Domain | PAC | 3.90e-03 | 26 | 67 | 2 | IPR001610 | |
| Domain | PAC | 3.90e-03 | 26 | 67 | 2 | SM00086 | |
| Domain | PAC | 3.90e-03 | 26 | 67 | 2 | PS50113 | |
| Domain | Galactose-bd-like | 4.69e-03 | 94 | 67 | 3 | IPR008979 | |
| Domain | Spectrin/alpha-actinin | 5.87e-03 | 32 | 67 | 2 | IPR018159 | |
| Domain | PAS | 5.87e-03 | 32 | 67 | 2 | SM00091 | |
| Domain | SPEC | 5.87e-03 | 32 | 67 | 2 | SM00150 | |
| Domain | PAS | 6.60e-03 | 34 | 67 | 2 | IPR000014 | |
| Domain | PAS | 6.60e-03 | 34 | 67 | 2 | PS50112 | |
| Domain | Cadherin_CS | 7.07e-03 | 109 | 67 | 3 | IPR020894 | |
| Pubmed | PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. | 3.98e-07 | 8 | 68 | 3 | 36115843 | |
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 21074528 | ||
| Pubmed | Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. | 8.49e-07 | 10 | 68 | 3 | 25974097 | |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.55e-06 | 12 | 68 | 3 | 14645221 | |
| Pubmed | Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells. | 3.77e-06 | 2 | 68 | 2 | 28152500 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8830046 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16311927 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 35945177 | ||
| Pubmed | Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. | 3.77e-06 | 2 | 68 | 2 | 24824748 | |
| Pubmed | Ciliary Hedgehog signaling regulates cell survival to build the facial midline. | 6.77e-06 | 19 | 68 | 3 | 34672258 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 14623077 | ||
| Pubmed | NPAS2 Compensates for Loss of CLOCK in Peripheral Circadian Oscillators. | 1.13e-05 | 3 | 68 | 2 | 26895328 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22396549 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 30819197 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12358783 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17637349 | ||
| Pubmed | Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. | 1.13e-05 | 3 | 68 | 2 | 11441146 | |
| Pubmed | Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. | 1.13e-05 | 3 | 68 | 2 | 24270424 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.13e-05 | 3 | 68 | 2 | 15744052 | |
| Pubmed | CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. | 1.13e-05 | 3 | 68 | 2 | 17417633 | |
| Pubmed | Circadian variation of blood pressure and the vascular response to asynchronous stress. | 1.13e-05 | 3 | 68 | 2 | 17360665 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17264841 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 26134245 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 31504229 | ||
| Pubmed | Breast cancer risk, nightwork, and circadian clock gene polymorphisms. | 1.13e-05 | 3 | 68 | 2 | 24919398 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17143338 | ||
| Pubmed | 1.23e-05 | 730 | 68 | 9 | 34857952 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9464277 | ||
| Pubmed | 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. | 2.25e-05 | 4 | 68 | 2 | 7574501 | |
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 2.25e-05 | 4 | 68 | 2 | 19922678 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 29671710 | ||
| Pubmed | [EXPRESSION OF PFKFB, HK2, NAMPT, TSPAN13 AND HSPB8 GENES IN PEDIATRIC GLIOMA]. | 2.25e-05 | 4 | 68 | 2 | 27491149 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 19829696 | ||
| Pubmed | Genetic components of the circadian clock regulate thrombogenesis in vivo. | 2.25e-05 | 4 | 68 | 2 | 18413500 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 10095107 | ||
| Pubmed | ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. | 2.25e-05 | 4 | 68 | 2 | 20368993 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 2837207 | ||
| Pubmed | Monocilia in the embryonic mouse heart suggest a direct role for cilia in cardiac morphogenesis. | 3.75e-05 | 5 | 68 | 2 | 18729223 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 18316400 | ||
| Pubmed | The centrosomal E3 ubiquitin ligase FBXO31-SCF regulates neuronal morphogenesis and migration. | 3.75e-05 | 5 | 68 | 2 | 23469015 | |
| Pubmed | CLOCK gene variants associate with sleep duration in two independent populations. | 3.75e-05 | 5 | 68 | 2 | 20149345 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 11439184 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 8940009 | ||
| Pubmed | Identification of positional candidate genes for body weight and adiposity in subcongenic mice. | 5.62e-05 | 6 | 68 | 2 | 17536020 | |
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 5.62e-05 | 6 | 68 | 2 | 20930143 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 28883095 | ||
| Pubmed | 5.91e-05 | 689 | 68 | 8 | 36543142 | ||
| Pubmed | 6.71e-05 | 40 | 68 | 3 | 32317081 | ||
| Pubmed | The trophoblast clock controls transport across placenta in mice. | 7.86e-05 | 7 | 68 | 2 | 33913482 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 15896703 | ||
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 7.86e-05 | 7 | 68 | 2 | 22510986 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 10409610 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 7819324 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 16059920 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 9576906 | ||
| Pubmed | PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. | 7.86e-05 | 7 | 68 | 2 | 18809579 | |
| Pubmed | Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. | 7.86e-05 | 7 | 68 | 2 | 22936566 | |
| Pubmed | The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes. | 1.05e-04 | 8 | 68 | 2 | 19204282 | |
| Pubmed | Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. | 1.05e-04 | 8 | 68 | 2 | 9885250 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 10037747 | ||
| Pubmed | 1.12e-04 | 971 | 68 | 9 | 33306668 | ||
| Pubmed | The activation and physiological functions of the proprotein convertases. | 1.34e-04 | 9 | 68 | 2 | 18343183 | |
| Pubmed | The prohormone theory and the proprotein convertases: it is all about serendipity. | 1.34e-04 | 9 | 68 | 2 | 21805236 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 21805237 | ||
| Pubmed | The biology and therapeutic targeting of the proprotein convertases. | 1.34e-04 | 9 | 68 | 2 | 22679642 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 23775089 | ||
| Pubmed | GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas. | 1.34e-04 | 9 | 68 | 2 | 23446420 | |
| Pubmed | Autonomous and non-cell autonomous role of cilia in structural birth defects in mice. | 1.34e-04 | 9 | 68 | 2 | 38079449 | |
| Pubmed | 1.40e-04 | 253 | 68 | 5 | 29911972 | ||
| Pubmed | 1.51e-04 | 257 | 68 | 5 | 30945288 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 16163737 | ||
| Pubmed | Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. | 1.68e-04 | 10 | 68 | 2 | 16528748 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 21098568 | ||
| Pubmed | Hedgehog signaling is critical for maintenance of the adult coronary vasculature in mice. | 1.68e-04 | 10 | 68 | 2 | 18568073 | |
| Pubmed | Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. | 1.68e-04 | 10 | 68 | 2 | 19934327 | |
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 27272319 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 37776236 | ||
| Pubmed | Loss of ciliary transition zone protein TMEM107 leads to heterotaxy in mice. | 2.45e-04 | 12 | 68 | 2 | 31887266 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 28069795 | ||
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 23918393 | ||
| Pubmed | Nubp2 is required for cranial neural crest survival in the mouse. | 2.45e-04 | 12 | 68 | 2 | 31733190 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 30931988 | ||
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 24853502 | ||
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 37179372 | ||
| Pubmed | SHH E176/E177-Zn2+ conformation is required for signaling at endogenous sites. | 2.90e-04 | 13 | 68 | 2 | 28263766 | |
| Pubmed | 3.33e-04 | 305 | 68 | 5 | 21244100 | ||
| Pubmed | A hypomorphic allele reveals an important role of inturned in mouse skeletal development. | 3.38e-04 | 14 | 68 | 2 | 25774014 | |
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 9373155 | ||
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 26035863 | ||
| Pubmed | Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. | 3.89e-04 | 15 | 68 | 2 | 14517255 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 4.29e-04 | 922 | 68 | 8 | 27609421 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 18272593 | ||
| Pubmed | PER2 variantion is associated with depression vulnerability. | 4.44e-04 | 16 | 68 | 2 | 19693801 | |
| Pubmed | Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst. | 4.44e-04 | 16 | 68 | 2 | 20876279 | |
| Pubmed | The ciliopathy gene Rpgrip1l is essential for hair follicle development. | 5.03e-04 | 17 | 68 | 2 | 25398052 | |
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 22357932 | ||
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 18330926 | ||
| Pubmed | Multiple essential roles for primary cilia in heart development. | 5.03e-04 | 17 | 68 | 2 | 23351706 | |
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 34446743 | ||
| Pubmed | CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. | 5.65e-04 | 18 | 68 | 2 | 20180986 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 4.48e-05 | 4 | 50 | 2 | 1077 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.08e-04 | 8 | 50 | 2 | 939 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.67e-04 | 9 | 50 | 2 | 973 | |
| GeneFamily | Dyneins, axonemal | 9.93e-04 | 17 | 50 | 2 | 536 | |
| GeneFamily | Cadherin related | 9.93e-04 | 17 | 50 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.93e-04 | 17 | 50 | 2 | 486 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.76e-07 | 191 | 68 | 6 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 169 | 68 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.41e-06 | 185 | 68 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.04e-05 | 189 | 68 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 68 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 1.07e-05 | 190 | 68 | 5 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 1.15e-05 | 193 | 68 | 5 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 193 | 68 | 5 | 7022b3ce6220d6d1722a4e2947630a8da002cdce | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 193 | 68 | 5 | 3083305b7ae09a37d7f45b915d49b2b396276822 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 193 | 68 | 5 | 1218e74ee5e00d230222b10acc50cb96201016b4 | |
| ToppCell | normal_Lung-T/NK_cells-CD4+_Th|normal_Lung / Location, Cell class and cell subclass | 1.21e-05 | 195 | 68 | 5 | d6c69f149f3d96fe83f920e38277dede102d04b5 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.21e-05 | 195 | 68 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.21e-05 | 195 | 68 | 5 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | normal_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 1.27e-05 | 197 | 68 | 5 | 80b3902ceea242148a1f1707c633f66afedf5183 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.44e-05 | 135 | 68 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.57e-05 | 147 | 68 | 4 | 9566398275cad79223db90ffe640830acf2db864 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 148 | 68 | 4 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 148 | 68 | 4 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 148 | 68 | 4 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.98e-05 | 149 | 68 | 4 | 3378d0fe79de6d7879fd48717ded5027593c785f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 8.40e-05 | 151 | 68 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 165 | 68 | 4 | 567c9f8fe29b5d34c2e39d9a17db54eba51ee559 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 165 | 68 | 4 | cdc05f4a3c2c301f537ae641314875e5ecc16510 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 165 | 68 | 4 | 2ebabe6fdbcf8765bcf9d98faf20da783c9d113d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 166 | 68 | 4 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 166 | 68 | 4 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 166 | 68 | 4 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 166 | 68 | 4 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 167 | 68 | 4 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 168 | 68 | 4 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 169 | 68 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 169 | 68 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 171 | 68 | 4 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 172 | 68 | 4 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 174 | 68 | 4 | 99d7421ad5eafe7751ef90698a92f683aa33bca8 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 174 | 68 | 4 | fee2ee3e888ce71f9f3f05d7dc8aaa9549480205 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 176 | 68 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-04 | 177 | 68 | 4 | f069197d39aacf7ad63be13133a6f3fd35d429ac | |
| ToppCell | RSV-Healthy-4|RSV / Virus stimulation, Condition and Cluster | 1.58e-04 | 178 | 68 | 4 | a5835951492c051443f3c30d45f9a7b1b2557477 | |
| ToppCell | RSV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 1.58e-04 | 178 | 68 | 4 | a6d71aebb5c462311f8ade24f659642b6b329633 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-04 | 179 | 68 | 4 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 180 | 68 | 4 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-04 | 181 | 68 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.72e-04 | 182 | 68 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-04 | 182 | 68 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.72e-04 | 182 | 68 | 4 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 71 | 68 | 3 | b0dbb059a7d05f825da608879b23aeebd6e9e61f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 71 | 68 | 3 | 149504ce72da0730074ea436fc2034ce8cb585d5 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-04 | 183 | 68 | 4 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 184 | 68 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 184 | 68 | 4 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 184 | 68 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 184 | 68 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-04 | 184 | 68 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.83e-04 | 185 | 68 | 4 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 1.83e-04 | 185 | 68 | 4 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.83e-04 | 185 | 68 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.83e-04 | 185 | 68 | 4 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.83e-04 | 185 | 68 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 186 | 68 | 4 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.87e-04 | 186 | 68 | 4 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 186 | 68 | 4 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.87e-04 | 186 | 68 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.87e-04 | 186 | 68 | 4 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-04 | 187 | 68 | 4 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-04 | 187 | 68 | 4 | 16fffe894a2c7d5186556ad000e0be229511fbdb | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 187 | 68 | 4 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 187 | 68 | 4 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.95e-04 | 188 | 68 | 4 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 68 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-04 | 188 | 68 | 4 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.98e-04 | 74 | 68 | 3 | 08874e430b4c9fcb2c1758c4178cb0c45671b125 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.99e-04 | 189 | 68 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 189 | 68 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.03e-04 | 190 | 68 | 4 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 190 | 68 | 4 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.03e-04 | 190 | 68 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-04 | 191 | 68 | 4 | f7a42a9d7493ea25cd8bd297c22e49e4bad7f0a4 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.07e-04 | 191 | 68 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|tumor_Lung / Location, Cell class and cell subclass | 2.07e-04 | 191 | 68 | 4 | 3e259eba83f8159d1a1a96b98d0e867fe547c5e7 | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Control / Disease state, Lineage and Cell class | 2.07e-04 | 191 | 68 | 4 | 03b5c5e0941c3402ab3f48cbf3da2a027d110421 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-04 | 191 | 68 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-04 | 191 | 68 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 2.11e-04 | 192 | 68 | 4 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.11e-04 | 192 | 68 | 4 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 192 | 68 | 4 | 494c5eca0f07fc761f26487a2b937c7056bbe594 | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.11e-04 | 192 | 68 | 4 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.16e-04 | 193 | 68 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 2.16e-04 | 193 | 68 | 4 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.16e-04 | 193 | 68 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| Drug | l-leucyl-l-tyrosine | 1.13e-05 | 15 | 68 | 3 | CID000070410 | |
| Drug | brazilin | 2.01e-05 | 18 | 68 | 3 | CID000073384 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.22e-05 | 190 | 68 | 6 | 2619_DN | |
| Drug | triethyltin | 2.39e-05 | 19 | 68 | 3 | CID005359541 | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; HL60; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 2972_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 5770_DN | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 4004_UP | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 7036_UP | |
| Drug | paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A | 2.80e-05 | 198 | 68 | 6 | 640_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 7174_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.88e-05 | 199 | 68 | 6 | 1509_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.88e-05 | 199 | 68 | 6 | 5309_DN | |
| Drug | melarsen oxide | 4.93e-05 | 24 | 68 | 3 | CID000030830 | |
| Drug | ylangene | 5.25e-05 | 4 | 68 | 2 | CID000019725 | |
| Disease | basal cell carcinoma (is_marker_for) | 1.33e-04 | 8 | 65 | 2 | DOID:2513 (is_marker_for) | |
| Disease | Seasonal Affective Disorder | 5.62e-04 | 16 | 65 | 2 | C0085159 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 5.91e-04 | 74 | 65 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.12e-03 | 206 | 65 | 4 | C0152013 | |
| Disease | Squamous cell carcinoma of esophagus | 1.22e-03 | 95 | 65 | 3 | C0279626 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.87e-03 | 29 | 65 | 2 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 1.87e-03 | 29 | 65 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.87e-03 | 29 | 65 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.87e-03 | 29 | 65 | 2 | C3658302 | |
| Disease | Stevens-Johnson Syndrome | 2.00e-03 | 30 | 65 | 2 | C0038325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VELHTQSQDRFVYTC | 1656 | Q09472 | |
| VSQIAVAYHNIRDID | 266 | Q9UJX2 | |
| VEVVHCRRTESQDVY | 11 | Q8NHU2 | |
| RNSEQVVQSVVHLYE | 2516 | Q12802 | |
| SIDRYVAIVQAVSAH | 151 | P32248 | |
| QETVRHSITEAIVAY | 1711 | Q96DT5 | |
| TRYEVIQHVEEQSKE | 566 | Q9P2G1 | |
| RVLCQETYIEIQTEH | 491 | Q5JWR5 | |
| VSNEQEVLRVHYRAA | 1926 | Q6UB98 | |
| VSRTEVSNNHVLIYV | 1411 | P20742 | |
| VYDVRNTSSHVQELV | 566 | Q6PCD5 | |
| CTHSVVSYADVRVER | 346 | Q99743 | |
| EHYTRQVVDCQLADV | 436 | P28838 | |
| EYEARCTHVVINEIT | 421 | Q4KMQ2 | |
| TFYNSQRHRVTDEEV | 501 | P30203 | |
| RTLDYEQSRQHTIFV | 2346 | Q14517 | |
| HLCTQVIEISEYRTQ | 256 | Q9Y2X3 | |
| TYNICSEVQVVNTER | 356 | Q86VH4 | |
| NVTALSVERYVAVVH | 151 | Q9HB89 | |
| EQHSVRTYEVCDVQR | 51 | P54760 | |
| VRVCERYHDKQEVTS | 301 | Q92952 | |
| VQHIIVFTATRYEDR | 431 | Q16549 | |
| IHVNRTYDEQVTSRA | 131 | Q9HCR9 | |
| ETQLQHVEDYSRILC | 281 | A8MZ36 | |
| QLHERVTQECAEYRA | 121 | Q92817 | |
| SIYLNVESVCTHRER | 431 | Q16875 | |
| VVNRVADHIQSRIVY | 226 | Q16877 | |
| LTQTEEQLHCTVYRG | 66 | O15527 | |
| REQQAVHRYVLTAVD | 191 | Q9P2E7 | |
| VTAVAYRLAEQHRQI | 456 | P19367 | |
| TVNHYSSVVIDRRFE | 11 | Q06190 | |
| YVIHRNSCEVEISRV | 201 | Q14541 | |
| YRENIVSEQAHILVD | 626 | P53708 | |
| QTYIIDHNRTVVRFQ | 331 | Q969R8 | |
| EHYNSVTRLVNIVTE | 276 | Q8N6M0 | |
| YQEALSRITSVVQQH | 461 | P34059 | |
| ISQRAVTHIYNEDIE | 236 | Q9C0G6 | |
| VITLHDVYENRTDVV | 86 | Q9UIK4 | |
| EQRRVQVYLHESTQD | 271 | Q13616 | |
| QVSHTYIRVRVIEES | 3531 | Q8TDW7 | |
| HIKETEQCVRSYETA | 846 | Q17RS7 | |
| HVYRVLQCQEEELTQ | 156 | Q9NXV2 | |
| SVAVLYSVEEQRQRH | 86 | O95834 | |
| TVHSRVFQILYRNEE | 66 | Q49AJ0 | |
| QQEEHYRIETRVSSS | 1056 | Q5VT52 | |
| CEQVRLQYEHTRSVG | 271 | Q9UDX3 | |
| RDNYVRTSEISAVHI | 361 | Q9BY12 | |
| HVSNVTVNYNVTVER | 1001 | P98161 | |
| IEQIIRNYARSESHT | 606 | O15226 | |
| RTYVEVVHQSVAQNS | 401 | Q13635 | |
| CTHTVVSYAEVRAER | 371 | O15516 | |
| NASYIHVQRDAVRTV | 331 | Q8NA57 | |
| QQRCIATYRVHDEGV | 241 | Q8TAF3 | |
| AINEVVTREYTINIH | 16 | P62899 | |
| HIIEETQVFRESQSV | 466 | Q9NTN9 | |
| YDVTDSRITHQIVDR | 366 | O00541 | |
| YSVAFCNHVRTEVEQ | 36 | Q9BZQ8 | |
| EIVQQLIDEYHAATR | 426 | P23258 | |
| TRDQYATITHNVCEE | 336 | Q9NXZ1 | |
| EVISQHLVSYRNIEE | 531 | P12270 | |
| VNRQHSREEKYVTVQ | 261 | Q5TCZ1 | |
| THIVAAYQERNVTTV | 211 | Q9H6L2 | |
| RHSTTEVSCQNQEYL | 481 | O60294 | |
| QTAREYAVSSRHNVI | 376 | Q6S545 | |
| LRYQTSQERVVDEHE | 1206 | Q8NFA0 | |
| QTVTLERHECYDVEN | 71 | Q6ZNA1 | |
| VSTYDDVLERHQETC | 191 | Q49AA0 | |
| VRYLEHVQAVITVNA | 501 | P16519 |